BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35126461)

  • 21. Survey of Human Chromosome 21 Gene Expression Effects on Early Development in
    Edie S; Zaghloul NA; Leitch CC; Klinedinst DK; Lebron J; Thole JF; McCallion AS; Katsanis N; Reeves RH
    G3 (Bethesda); 2018 Jul; 8(7):2215-2223. PubMed ID: 29760202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered chromosome-based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome-associated heart defects in mice.
    Liu C; Morishima M; Jiang X; Yu T; Meng K; Ray D; Pao A; Ye P; Parmacek MS; Yu YE
    Hum Genet; 2014 Jun; 133(6):743-53. PubMed ID: 24362460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects.
    Piccoli C; Izzo A; Scrima R; Bonfiglio F; Manco R; Negri R; Quarato G; Cela O; Ripoli M; Prisco M; Gentile F; Calì G; Pinton P; Conti A; Nitsch L; Capitanio N
    Hum Mol Genet; 2013 Mar; 22(6):1218-32. PubMed ID: 23257287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome.
    Pereira PL; Magnol L; Sahún I; Brault V; Duchon A; Prandini P; Gruart A; Bizot JC; Chadefaux-Vekemans B; Deutsch S; Trovero F; Delgado-García JM; Antonarakis SE; Dierssen M; Herault Y
    Hum Mol Genet; 2009 Dec; 18(24):4756-69. PubMed ID: 19783846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21.
    Lyle R; Béna F; Gagos S; Gehrig C; Lopez G; Schinzel A; Lespinasse J; Bottani A; Dahoun S; Taine L; Doco-Fenzy M; Cornillet-Lefèbvre P; Pelet A; Lyonnet S; Toutain A; Colleaux L; Horst J; Kennerknecht I; Wakamatsu N; Descartes M; Franklin JC; Florentin-Arar L; Kitsiou S; Aït Yahya-Graison E; Costantine M; Sinet PM; Delabar JM; Antonarakis SE
    Eur J Hum Genet; 2009 Apr; 17(4):454-66. PubMed ID: 19002211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genetic background and application of Down syndrome mouse models.
    Meng XW; Wang J; Ma QW
    Yi Chuan; 2018 Mar; 40(3):207-217. PubMed ID: 29576544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression.
    Lu J; Mccarter M; Lian G; Esposito G; Capoccia E; Delli-Bovi LC; Hecht J; Sheen V
    Hum Mol Genet; 2016 May; 25(9):1714-27. PubMed ID: 26911678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathways to cognitive deficits in Down syndrome.
    Sturgeon X; Le T; Ahmed MM; Gardiner KJ
    Prog Brain Res; 2012; 197():73-100. PubMed ID: 22541289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine-related oxidative stress and mitochondrial dysfunction in dopaminergic neurons differentiated from deciduous teeth-derived stem cells of children with Down syndrome.
    Sun X; Kato H; Sato H; Han X; Hirofuji Y; Kato TA; Sakai Y; Ohga S; Fukumoto S; Masuda K
    FASEB Bioadv; 2022 Jul; 4(7):454-467. PubMed ID: 35812076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance.
    Prandini P; Deutsch S; Lyle R; Gagnebin M; Delucinge Vivier C; Delorenzi M; Gehrig C; Descombes P; Sherman S; Dagna Bricarelli F; Baldo C; Novelli A; Dallapiccola B; Antonarakis SE
    Am J Hum Genet; 2007 Aug; 81(2):252-63. PubMed ID: 17668376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The transcriptome profile of human trisomy 21 blood cells.
    Antonaros F; Zenatelli R; Guerri G; Bertelli M; Locatelli C; Vione B; Catapano F; Gori A; Vitale L; Pelleri MC; Ramacieri G; Cocchi G; Strippoli P; Caracausi M; Piovesan A
    Hum Genomics; 2021 May; 15(1):25. PubMed ID: 33933170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penetrance of Congenital Heart Disease in a Mouse Model of Down Syndrome Depends on a Trisomic Potentiator of a Disomic Modifier.
    Li H; Edie S; Klinedinst D; Jeong JS; Blackshaw S; Maslen CL; Reeves RH
    Genetics; 2016 Jun; 203(2):763-70. PubMed ID: 27029737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down's syndrome-like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse.
    Dunlevy L; Bennett M; Slender A; Lana-Elola E; Tybulewicz VL; Fisher EM; Mohun T
    Cardiovasc Res; 2010 Nov; 88(2):287-95. PubMed ID: 20558441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional genomics of Down syndrome: a multidisciplinary approach.
    Dierssen M; Martí E; Pucharcós C; Fotaki V; Altafaj X; Casas K; Solans A; Arbonés ML; Fillat C; Estivill X
    J Neural Transm Suppl; 2001; (61):131-48. PubMed ID: 11771739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural Characterization of the Highly Restricted Down Syndrome Critical Region on 21q22.13: New
    Antonaros F; Pitocco M; Abete D; Vione B; Piovesan A; Vitale L; Strippoli P; Caracausi M; Pelleri MC
    Front Genet; 2021; 12():770359. PubMed ID: 34956324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated Quantitative Transcriptome Maps of Human Trisomy 21 Tissues and Cells.
    Pelleri MC; Cattani C; Vitale L; Antonaros F; Strippoli P; Locatelli C; Cocchi G; Piovesan A; Caracausi M
    Front Genet; 2018; 9():125. PubMed ID: 29740474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies.
    Korbel JO; Tirosh-Wagner T; Urban AE; Chen XN; Kasowski M; Dai L; Grubert F; Erdman C; Gao MC; Lange K; Sobel EM; Barlow GM; Aylsworth AS; Carpenter NJ; Clark RD; Cohen MY; Doran E; Falik-Zaccai T; Lewin SO; Lott IT; McGillivray BC; Moeschler JB; Pettenati MJ; Pueschel SM; Rao KW; Shaffer LG; Shohat M; Van Riper AJ; Warburton D; Weissman S; Gerstein MB; Snyder M; Korenberg JR
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12031-6. PubMed ID: 19597142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down syndrome: searching for the genetic culprits.
    Lana-Elola E; Watson-Scales SD; Fisher EM; Tybulewicz VL
    Dis Model Mech; 2011 Sep; 4(5):586-95. PubMed ID: 21878459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondria as pharmacological targets in Down syndrome.
    Valenti D; Braidy N; De Rasmo D; Signorile A; Rossi L; Atanasov AG; Volpicella M; Henrion-Caude A; Nabavi SM; Vacca RA
    Free Radic Biol Med; 2018 Jan; 114():69-83. PubMed ID: 28838841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trisomy 21 and Down syndrome: a short review.
    Sommer C; Henrique-Silva F
    Braz J Biol; 2008 May; 68(2):447-52. PubMed ID: 18660978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.